Abstract
Introduction and hypothesis: On April 16, 2019, the United States Food and Drug Administration announced a withdrawal on sales and distribution of transvaginal mesh products for pelvic organ prolapse. The aim of this study was to asses online user behavior on pelvic-mesh related articles after the withdrawal and to evaluate article accuracy.
Original language | English (US) |
---|---|
Pages (from-to) | 375-379 |
Number of pages | 5 |
Journal | International Urogynecology Journal |
Volume | 32 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2021 |
Keywords
- FDA mesh
- Pelvic organ prolapse
- Transvaginal mesh
- Vaginal mesh
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Urology